Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomasHélène Lasolle, Gérald Raverot, Christine Cortet et al.|European Journal of Endocrinology|2017Cited by 142
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Annabelle Esvant, Lucile Offredo et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 124
French expert consensus statement on diagnosis and management of primary hyperparathyroidismMarie‐Christine Vantyghem, V. Kerlan, Éric Mirallié et al.|Annales d Endocrinologie|2025Cited by 4
O72 Fréquence, prise en charge et coût médico-économique des hypoglycémies sévères gérées par le SAMU: résultats de l’étude nationale multicentrique HYPO15Nicolas Chevalier, Rachel Desailloud, P. Böhme et al.|Diabetes & Metabolism|2015Cited by 2
OR04-4 Loss of KDM1A in Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome and in Acromegaly With Paradoxical GH Response to Oral GlucoseLarbi Amazit, Fanny Chasseloup, Mattia Barbot et al.|Journal of the Endocrine Society|2022Cited by 2